Fresh Tracks Therapeutics Inc (FRTX) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fresh Tracks Therapeutics Inc   (FRTX)


Fresh Tracks Therapeutics Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fresh Tracks Therapeutics Inc's ROI in the fourth quarter of 2023?
Fresh Tracks Therapeutics Inc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -58.8%.

Within the Healthcare sector 605 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2023 quarter, so far to 4135, from total ROI ranking in the third quarter of 2023 at 4196.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -22.68 % -46.91 % -52.62 % -47.26 % -48.19 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 10 11 8 10 7
Return On Investment (TTM) -58.8 % -102 % -188.61 % -145.43 % -168.47 %
FRTX's Overall Ranking # 4135 # 4196 # 4594 # 3395 # 4715
Seq. Investment Change TTM 7.6 % -0.76 % -17.41 % -12.34 % -26.12 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -9 -17 -16 -21

FRTX Company Profile >> Back to FRTX Roi Comparisons >> See Annual FRTX Return On Investment



Return On Investment FRTX's Ranking
Within: No.
Industry # 94
Sector # 606
Overall # 4135

Return On Investment Statistics
High Average Low
-11.36 %
-64.17 %
-191.43 %
(Dec 31 2019)   (Mar 31 2022)







Financial Statements
Fresh Tracks Therapeutics Inc's IV. Quarter Investments $ 10 Millions FRTX's Balance sheet
Fresh Tracks Therapeutics Inc's IV. Quarter Income $ -1 Millions Quarterly FRTX's Income Statement
FRTX's Income by Division See FRTX's Income by Division


FRTX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 10 7 25 27 8
Y / Y Investment Growth 38.03 % -71.12 % -8.7 % 260.19 % -84.47 %
Net Income in Millions -6 -21 -39 -21 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment -57.34 % -293.33 % -158.49 % -76.66 % -43.95 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FRTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FRTX's Competitors
Subscribers only: Roi for Fresh Tracks Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FRTX's Customers

Other Ratios
FRTX's Roa FRTX's Inventory Turnover Ratio FRTX's Growth Rates FRTX's Dividend Statistics
FRTX's Profitability Ratios FRTX's Asset Turnover Ratio FRTX's Dividend Growth
FRTX's Roe FRTX's Valuation Ratios FRTX's Financial Strength Ratios FRTX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-06-22T14:32:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.